Bacterial vaginosis (Bacterial Vaginosis – BV) is a common infection caused by a violation of the natural balance of the vaginal flora and an overgrowth of conditionally pathogenic bacteria. Bacterial vaginosis affects mostly women of reproductive age group. According to the US Centers for Disease Control and Prevention (CDC), it affects 29.2% of women.
In the diagnosis of bacterial vaginosis, the examination of the vaginal flora is of clinical importance as it determines the ratio between normal vaginal flora and pathogenic microorganisms.
This ratio is detected with high accuracy by the Bacterial Vaginosis Real-TM Quant reactive kit, which quantifies Gardnerella vaginalis, Atopobium vaginae and Lactobacillus spp in the vaginal biotope and simultaneously shows the total bacterial count.
Bacterial Vaginosis Real-TM Quant kit allows to determine the total bacteria quantity in the vaginal biotope, to value the ratio among lactobacilli and other facultative and anaerobic species (Gardnerella vaginalis, Atopobium vaginae), which is important in determining treatment tactics.
Intravaginal interventions increase the risk of bacterial vaginosis, therefore for the prevention of bacterial vaginosis it is important to use:
The following factors also increase the risk of bacterial vaginosis:
The following complications are regarded as to the Bacterial Vaginosis:
85% of women with bacterial vaginosis does not have any symptom, although in some cases symptoms may occur, among which the most common are: